MENU
+Compare
OTLK
Stock ticker: NASDAQ
AS OF
Jun 13 closing price
Price
$1.82
Change
-$0.02 (-1.09%)
Capitalization
77.99M

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications... Show more

Industry: #Biotechnology
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OTLK with price predictions
Jun 13, 2025

OTLK's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for OTLK moved out of overbought territory on May 14, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where OTLK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on June 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OTLK as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OTLK turned negative on June 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OTLK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OTLK broke above its upper Bollinger Band on May 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

OTLK moved above its 50-day moving average on May 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OTLK advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 150 cases where OTLK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OTLK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.972). P/E Ratio (0.445) is within average values for comparable stocks, (59.618). OTLK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.336). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (257.692).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OTLK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OTLK is expected to report earnings to fall 34.44% to -98 cents per share on May 15

Outlook Therapeutics OTLK Stock Earnings Reports
Q1'24
Est.
$-0.98
Q1'25
Missed
by $1.44
Q4'23
Beat
by $0.19
Q3'23
Missed
by $0.94
Q2'23
Missed
by $1.55
The last earnings report on May 15 showed earnings per share of -150 cents, missing the estimate of -5 cents. With 302.64K shares outstanding, the current market capitalization sits at 77.99M.
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
485 Route 1 South Building F
Phone
+1 609 619-3990
Employees
24
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRK81.71-0.11
-0.13%
Merck & Co
VRNA92.20-0.30
-0.32%
Verona Pharma plc
GLAD26.70-0.43
-1.58%
Gladstone Capital Corp
ATEC11.06-0.31
-2.73%
Alphatec Holdings
ELUT1.78-0.11
-5.82%
Elutia

OTLK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with CYTK. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
-1.09%
CYTK - OTLK
33%
Loosely correlated
+3.55%
PDSB - OTLK
33%
Loosely correlated
-2.23%
MCRB - OTLK
32%
Poorly correlated
-6.13%
VIR - OTLK
31%
Poorly correlated
N/A
ALXO - OTLK
30%
Poorly correlated
-5.23%
More